AU8163798A - Cloning of a gene mutation for parkinson's disease - Google Patents

Cloning of a gene mutation for parkinson's disease

Info

Publication number
AU8163798A
AU8163798A AU81637/98A AU8163798A AU8163798A AU 8163798 A AU8163798 A AU 8163798A AU 81637/98 A AU81637/98 A AU 81637/98A AU 8163798 A AU8163798 A AU 8163798A AU 8163798 A AU8163798 A AU 8163798A
Authority
AU
Australia
Prior art keywords
parkinson
cloning
disease
gene mutation
mutation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU81637/98A
Inventor
Roger C. Duvoisin
William G. Johnson
Christian Lavedan
Elisabeth Leroy
Robert L. Nussbaum
Mihael H. Polymeropoulos
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
US Department of Health and Human Services
Original Assignee
US Department of Health and Human Services
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by US Department of Health and Human Services filed Critical US Department of Health and Human Services
Publication of AU8163798A publication Critical patent/AU8163798A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AU81637/98A 1997-06-25 1998-06-25 Cloning of a gene mutation for parkinson's disease Abandoned AU8163798A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US5068497P 1997-06-25 1997-06-25
US60050684 1997-06-25
PCT/US1998/013071 WO1998059050A1 (en) 1997-06-25 1998-06-25 Cloning of a gene mutation for parkinson's disease

Publications (1)

Publication Number Publication Date
AU8163798A true AU8163798A (en) 1999-01-04

Family

ID=21966755

Family Applications (1)

Application Number Title Priority Date Filing Date
AU81637/98A Abandoned AU8163798A (en) 1997-06-25 1998-06-25 Cloning of a gene mutation for parkinson's disease

Country Status (2)

Country Link
AU (1) AU8163798A (en)
WO (1) WO1998059050A1 (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9719879D0 (en) * 1997-09-19 1997-11-19 Neuropa Ltd Protein
AU3117799A (en) * 1998-03-30 1999-10-18 Trustees Of The University Of Pennsylvania, The Method of identifying, diagnosing and treating synuclein positive neurodegenerative disorders
EP1081225A1 (en) * 1999-08-30 2001-03-07 Biofrontera Pharmaceuticals GmbH Transgenic animal model for neurodegenerative diseases
US7399900B2 (en) 2000-03-22 2008-07-15 Sanofi-Aventis Deutschland Gmbh Nematodes as model organisms for the investigation of neurodegenerative diseases, in particular parkinsons disease, uses and methods for the discovery of substances and genes which can used in the treatment of the above disease states and identification of anematode gene
CN1440420A (en) 2000-07-07 2003-09-03 万能药制药公司 Methods for preventing neural tissue damage and for the treatment of alpha-synuclein diseases
WO2002075317A2 (en) * 2001-03-15 2002-09-26 Novartis Ag Screening for drugs against disorders associated with schizophrenia
US8506959B2 (en) 2002-11-01 2013-08-13 Neotope Biosciences Limited Prevention and treatment of synucleinopathic and amyloidogenic disease
WO2008103472A2 (en) 2007-02-23 2008-08-28 Elan Pharmaceuticals, Inc. Prevention and treatment of synucleinopathic and amyloidogenic disease
TW200509968A (en) 2002-11-01 2005-03-16 Elan Pharm Inc Prevention and treatment of synucleinopathic disease
JP4613824B2 (en) * 2003-10-30 2011-01-19 大正製薬株式会社 Transgenic non-human mammal
EA013752B1 (en) 2004-08-09 2010-06-30 Элан Фармасьютикалз, Инк. Prevention and treatment of synucleinopathic and amyloidogenic disease
EP3067066B1 (en) 2007-02-23 2019-03-27 Prothena Biosciences Limited Prevention and treatment of synucleinopathic and amyloidogenic disease

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5494794A (en) * 1992-10-20 1996-02-27 Emory University Detection of mitochondrial DNA mutations associated with Alzheimer's disease and Parkinson's disease

Also Published As

Publication number Publication date
WO1998059050A9 (en) 1999-04-15
WO1998059050A1 (en) 1998-12-30

Similar Documents

Publication Publication Date Title
AU2822195A (en) Mutant dwarfism gene of petunia
AU3225897A (en) Regulation of gene expression
AU1608999A (en) A pathogen and stress-responsive promoter for gene expression
AU4787697A (en) Therapeutic gene
AU4172599A (en) A process for inhibiting expression of genes
AU6011496A (en) Improved pharmaceutical compositions for gene therapy
AU6614696A (en) Inhibition of gene expression
AUPN245295A0 (en) Assay for genetic abnormalities
AU6614596A (en) Inhibition of gene expression
AU8163798A (en) Cloning of a gene mutation for parkinson's disease
AU6679296A (en) Hepadnavirus receptor
AU1175497A (en) A class of oligonucleotides, therapeutically useful as antitumoural agents
AU4954496A (en) Gene transfer preparation
AU8758298A (en) Process for the preparation of 2'-fluoro-5-methyl-beta -l-arabinofuranosyluridine
AU8182098A (en) Parkinson's disease tests
AU6271598A (en) Targeted modification of the ccr-5 gene
AU6343196A (en) Mutant s182 genes
AU1140101A (en) Improved mutation analysis of the nf1 gene
AU6659998A (en) Tazarotene-induced gene 3 (tig3)
AU2208199A (en) Cloning of a high growth gene
AU5102799A (en) Multiple splice variants of the mu-opioid receptor gene
AUPO947997A0 (en) Method of regulating gene expression
AU6960396A (en) Batten disease gene
AU4941096A (en) Self-deleting vectors for gene therapy
AU6433499A (en) Tnfr related gene 12

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase